Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone combination therapy effects on airway wall thickness and hyperresponsiveness in asthma
ACTRN12610000561088Phase 4Completed
- Sponsor
- Woolcock Institute of Medical Research
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of salmeterol + fluticasone in asthma, sponsored by Woolcock Institute of Medical Research. Started Aug 2008; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on ACTRN12610000561088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000561088.